kabutan

Pharma Foods International Co., Ltd., 56% Decrease in Ordinary Profit for The Current Fiscal Year

Thu Sep 12, 2024 3:00 pm JST Earnings

2929 Pharma Foods International Co., Ltd. 【J-GAAP】

Earnings Report

Pharma Foods International Co., Ltd. <2929> [TSE-P] announced its financial results after the market closed on September 12th (15:00). The consolidated ordinary profit for the fiscal year ending July 2024 expanded to 48.3% from the previous period to 5.24 billion yen. However, for the fiscal year ending July 2025 is also bleak, with an expected significant drop by 56.2% from the previous period to 2.3 billion yen.

In the most recent three-month period, from May to July (4Q), the consolidated ordinary profit grew by 3.5% from the same period last year, reaching 2.02 billion yen. The operating profit margin remained almost flat, changing from 12.3% in the same period last year to 12.3%.

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul, 2022 60,185 1,080 1,264 -374 -12.9 20 Sep 6, 2022 J-GAAP
Jul, 2023 68,572 3,610 3,540 3,081 106.7 22 Sep 11, 2023 J-GAAP
Jul, 2024 62,147 5,113 5,249 3,205 112.7 25 Sep 12, 2024 J-GAAP
YoY -9.4% +41.6% +48.3% +4.0% +5.6%

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul, 2024 Guidance 62,000 5,000 5,100 3,500 124.7 25 Jul 25, 2024 J-GAAP
Jul, 2024 Results 62,147 5,113 5,249 3,205 112.7 25 Sep 12, 2024 J-GAAP
Revision Rate +0.2% +2.3% +2.9% -8.4% -9.6%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Aug - Jan, 2023 31,652 1,535 1,542 768 26.7 10 Mar 11, 2024 J-GAAP
Aug - Jan, 2024 Guidance ー ー ー ー － 12.50 Sep 12, 2024 J-GAAP
YoY － － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul, 2023 68,572 3,610 3,540 3,081 106.7 22 Sep 11, 2023 J-GAAP
Jul, 2024 62,147 5,113 5,249 3,205 112.7 25 Sep 12, 2024 J-GAAP
Jul, 2025 Guidance 65,000 2,000 2,300 1,600 55.4 25 Sep 12, 2024 J-GAAP
YoY +4.6% -60.9% -56.2% -50.1% -50.8%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
May - Jul, 2023 16,039 1,976 1,958 2,013 69.7 12.3 Sep 11, 2023 J-GAAP
Aug - Oct, 2023 16,142 601 605 286 9.9 3.7 Dec 11, 2023 J-GAAP
Nov - Jan, 2023 15,510 934 937 482 16.7 6.0 Mar 11, 2024 J-GAAP
Feb - Apr, 2024 15,519 1,731 1,681 1,088 38.1 11.2 Jun 10, 2024 J-GAAP
May - Jul, 2024 14,976 1,847 2,026 1,349 47.4 12.3 Sep 12, 2024 J-GAAP
YoY -6.6% -6.5% +3.5% -33.0% -31.9%

Related Articles